Clinical Guides
Endometriosis: Recognition, Diagnosis and Management Principles
An India-contextualised educational guide to recognising suspected endometriosis, structuring a safe diagnostic pathway and understanding shared, fertility-aware management decisions; it is not an individual treatment plan.
MedNext Academy | 15 min read
Endometriosis: Recognition, Diagnosis and Management Principles
An India-contextualised educational guide to recognising suspected endometriosis, structuring a safe diagnostic pathway and understanding shared, fertility-aware management decisions; it is not an individual treatment plan.
Summary
Endometriosis is a chronic inflammatory condition in which tissue resembling the endometrium is found outside the uterine cavity. It most often involves pelvic structures, where inflammation, fibrosis and adhesions may contribute to dysmenorrhoea, non-menstrual pelvic pain, deep dyspareunia, bowel or urinary symptoms that vary with the cycle, and subfertility. Symptoms, lesion burden and imaging findings do not always correlate; a person may have substantial pain with limited visible disease, or little pain despite disease found incidentally. The condition is not caused by a patient’s behaviour, and pain should not be dismissed as a normal or inevitable part of menstruation.
For clinical learning, the central task is to recognise a pattern, exclude urgent alternatives, document the patient’s priorities and choose proportionate next steps. A careful history and examination remain important even when imaging is planned. Current WHO material states that there is no known cure, but symptoms can be managed with medicines and, for selected patients, surgery. Choice depends on symptom burden, adverse-effect profile, cost and availability, coexisting conditions, and whether pregnancy is desired now or later. The 2022 ESHRE guideline similarly frames care as shared decision-making rather than a single mandatory sequence.
A negative ultrasound or MRI does not exclude superficial peritoneal disease. Conversely, laparoscopy is no longer understood as an automatic first diagnostic step for every patient with suggestive symptoms. It may be considered when imaging is negative and empirical treatment is unsuccessful or unsuitable, or when operative assessment is likely to change management. This guide is for supervised medical education: individual diagnosis, prescribing, surgery and fertility planning require an appropriately qualified clinician and the patient’s informed preferences.
How Common Is It?
WHO estimates that endometriosis affects about 10% of women of reproductive age globally, approximately 190 million people. It can begin from menarche and may remain symptomatic through the reproductive years; symptoms can also persist or recur after treatment. The estimate should be used carefully in clinical teaching: it is a global estimate, not an India-specific prevalence figure, and diagnosis is influenced by access to care, symptom recognition and the diagnostic method used. A student should not infer that a fixed proportion of people presenting with dysmenorrhoea have endometriosis.
The public-health burden is wider than lesion detection. WHO describes severe period pain, chronic pelvic pain, heavy bleeding, fatigue, infertility, painful sex, bowel or urinary symptoms, anxiety and depression as potential contributors to impaired quality of life. Symptoms can disrupt attendance, work, relationships and sexual health. Stigma and normalisation of painful periods can delay presentation or referral. These effects make it clinically important to ask about function: days missed from study or work, sleep disturbance, analgesic use, avoidance of activity or intercourse, and the patient’s own concerns about fertility.
Among people evaluated for infertility, WHO notes that endometriosis is found in a substantial minority, quoted as 25–50%. That association does not prove causation in an individual couple and must not be used to promise that treating visible disease will restore fertility. The educational implication is to take a concurrent fertility history and to avoid delaying appropriate fertility assessment simply because pain is the presenting complaint. Equally, absence of infertility does not rule out endometriosis.
Risk Factors
The cause of endometriosis is not established. It is more accurate to describe associated patterns and clinical clues than to offer a simple causal story. A family history may increase suspicion, and a history of early-onset, progressively worsening or function-limiting dysmenorrhoea should prompt focused assessment. ESHRE advises considering endometriosis with cyclical or non-cyclical pelvic pain, dysmenorrhoea, deep dyspareunia, dyschezia, dysuria, painful rectal bleeding or haematuria occurring with menstruation, shoulder-tip pain linked to the cycle, catamenial pneumothorax, fatigue or infertility. These are prompts for assessment, not diagnostic criteria in isolation.
Risk assessment should also identify factors that change urgency or the differential. Ask about the possibility of pregnancy, prior pelvic surgery, pelvic inflammatory disease, sexually transmitted infection risk, previous ovarian cysts, bowel disease, urinary symptoms, weight loss, fever, abnormal discharge, bowel obstruction symptoms and a personal or family history suggestive of malignancy. Record the temporal relation of symptoms to menstruation, ovulation and hormonal treatment. A symptom diary can make patterns visible, but it is not a diagnostic test.
Avoid implying that exercise, diet, stress, contraceptive use or a particular food caused endometriosis. Patients may encounter unsupported claims online, including promises of cure through supplements or restrictive diets. Lifestyle support, sleep, movement within tolerance and psychological support may help overall wellbeing, but they do not replace evidence-based assessment. A non-judgemental history is particularly important because sexual pain, fertility concerns and menstrual symptoms may be difficult to disclose.
In adolescents, severe dysmenorrhoea that does not respond as expected to initial measures deserves review rather than repeated reassurance. However, pelvic examination and imaging should be individualised, with attention to consent, privacy, safeguarding and the person’s developmental context.
Diagnosis
History
Begin by establishing safety. In a person of reproductive potential with pelvic pain, ask about the last menstrual period, contraception, pregnancy possibility, vaginal bleeding, syncope, shoulder-tip pain and haemodynamic symptoms; pregnancy testing and urgent assessment may be necessary to exclude ectopic pregnancy or miscarriage. Then characterise pain by site, onset, severity, duration, cycle relation, progression, analgesic response and functional effect. Ask specifically about dysmenorrhoea, non-menstrual pelvic pain, deep dyspareunia, dyschezia, cyclical bowel symptoms, dysuria, cyclical haematuria, painful defaecation, fatigue and infertility. ESHRE recommends considering endometriosis in people with these patterns.
A complete history includes menstrual pattern and bleeding, obstetric and fertility history, previous imaging or surgery, past diagnoses of irritable bowel syndrome, inflammatory bowel disease, urinary disease or pelvic infection, medicines and contraindications to hormonal treatment. Clarify whether the current priority is pain relief, contraception, preserving future fertility, trying to conceive, or understanding a pelvic mass. These priorities influence the discussion but should not be confused with a diagnosis.
Examination
Examination is guided by symptoms, consent and setting. General examination should look for pallor, fever, haemodynamic instability or systemic illness. Abdominal examination may identify tenderness, guarding, distension or a palpable mass. Where clinically appropriate and consented, speculum and bimanual examination can assess cervical or vaginal lesions, uterine mobility, adnexal mass, posterior fornix tenderness or nodularity, and pelvic-floor tenderness. A normal examination does not exclude endometriosis; ESHRE recommends further diagnostic steps, including imaging, when suspicion remains. Examination should never be forced or framed as a test of credibility.
Investigations
A urine pregnancy test is an early safety investigation when pregnancy is possible. Further laboratory tests are selected for the differential, for example a complete blood count when heavy bleeding or anaemia is suspected, urinalysis for urinary symptoms, or infection testing when indicated. There is no validated blood, menstrual-fluid, urine or saliva biomarker that should be used routinely to diagnose endometriosis; ESHRE recommends against such testing.
Pelvic ultrasound, usually transvaginal when appropriate and acceptable, is an important first imaging modality for ovarian endometrioma and some forms of deep disease, and can identify alternative structural pathology. MRI may be useful where expertise and a specific clinical question justify it, particularly for mapping suspected deep disease. Imaging quality and interpretation matter. A negative study does not exclude superficial peritoneal endometriosis. Laparoscopy can permit diagnosis and treatment, but should be considered in context rather than used solely because symptoms are real. Histology is useful when tissue is obtained, but a negative histology result does not by itself rule out disease if the specimen is inadequate or lesions were not sampled.
Differential Diagnosis
Endometriosis is a diagnosis to consider, not a label to apply before assessing alternatives. The differential for cyclical or chronic pelvic pain includes primary dysmenorrhoea, adenomyosis, leiomyoma, ovarian cysts, pelvic inflammatory disease, ectopic pregnancy, miscarriage, urinary tract pathology, interstitial cystitis or bladder pain syndrome, irritable bowel syndrome, inflammatory bowel disease, constipation, pelvic-floor myalgia, neuropathic pain and abdominal wall pain. The differential shifts with age, pregnancy possibility, bleeding pattern and examination findings.
Adenomyosis may coexist with endometriosis and can contribute to heavy, painful periods and a tender or enlarged uterus. Ovarian endometrioma must be distinguished from functional, haemorrhagic, dermoid and neoplastic cysts. An adnexal mass, persistent symptoms after menopause, unintentional weight loss, persistent intermenstrual or postcoital bleeding, or new symptoms without a typical cycle relation require a broader evaluation rather than automatic attribution to endometriosis.
Condition-specific Indian national guidance located for this draft did not provide a dated, comprehensive endometriosis pathway, so the diagnostic framework is deliberately anchored to WHO and ESHRE rather than implying an Indian protocol that does not exist. The practical message for learners is to consider coexisting structural, endocrine, pregnancy-related and infectious causes of bleeding and pain. Do not use a presumed endometriosis diagnosis to delay pregnancy testing, sepsis assessment, cancer evaluation or referral for an enlarging pelvic mass.
Diagnostic overlap also explains why multidisciplinary care may be useful. Bowel, urinary, pain and mental-health symptoms may each need their own assessment. A respectful explanation of uncertainty is safer than either over-investigation or certainty based on one symptom.
Management
Management begins with shared goals. Clarify whether the person is trying to conceive, wants contraception, prioritises pain control, has an endometrioma or suspected deep disease, and has previously tried medicines or surgery. Explain that treatment aims to reduce symptoms and improve quality of life; no current treatment guarantees cure or prevents recurrence in every patient. The WHO fact sheet emphasises that treatment choices should account for severity, preferences, safety, costs, availability and reproductive goals.
For pain, non-steroidal anti-inflammatory drugs or other analgesics may be used when clinically appropriate, with attention to renal disease, gastrointestinal risk, asthma sensitivity, anticoagulants, pregnancy and drug interactions. Hormonal approaches can reduce pain for many patients who are not actively trying to conceive. ESHRE recommends hormone treatment as an option and lists combined hormonal contraceptives, progestogens and selected long-acting methods; the choice should be individualised. These medicines have contraceptive effects or other implications, so they are not a fertility treatment and should not be presented as one.
GnRH agonists or antagonists and aromatase inhibitors are specialist-directed options in selected circumstances, generally after consideration of first-line hormonal choices and adverse effects. ESHRE advises that GnRH agonists be second-line because of their side-effect profile and that add-back therapy be considered to reduce hypo-oestrogenic symptoms and bone loss. Students should understand the principle rather than initiate these drugs independently.
Surgery is one possible option for pain, endometrioma, deep disease, an anatomic problem relevant to fertility, or when diagnosis and treatment are both needed. It should be discussed with realistic expectations: symptoms can recur, surgery can affect ovarian reserve, and complex disease may require an experienced multidisciplinary team. Hysterectomy is not a universal cure and is not a default treatment for people wishing to retain fertility. For infertility, medical suppression does not improve spontaneous pregnancy rates when used solely to enhance fertility; assessment and assisted-reproduction choices should be individualised by a fertility specialist. Supportive pain care, pelvic physiotherapy and psychological interventions may be considered as part of broader care, without promising a cure.
Prescribing Information
This section is a prescribing-safety framework, not a dose chart. Before prescribing analgesic or hormonal treatment, confirm the diagnosis is not masking an emergency, establish pregnancy status where relevant, take a medicine and thrombotic-risk history, review blood pressure and migraine history where appropriate, and check contraindications, interactions and local product information. Document the therapeutic aim, expected benefit, adverse effects to watch for, contraception implications and a planned review point.
NSAIDs are commonly used for pain, but their risks are clinically important: gastrointestinal injury or bleeding, renal impairment, fluid retention, interaction with anticoagulants and possible asthma exacerbation. They should be selected and monitored according to the individual’s comorbidities and concurrent medicines. If pain remains severe despite initial treatment, escalating self-medication is not a substitute for reassessment.
Combined hormonal contraception and progestogen-based therapies may reduce endometriosis-associated pain. Selection depends on eligibility, adverse-effect profile, bleeding tolerance, adherence, cost and pregnancy intention. ESHRE recommends taking differing progestogen side-effect profiles into account. A levonorgestrel-releasing intrauterine system or etonogestrel implant can be options for pain in selected patients, but insertion, follow-up and contraindications require routine contraceptive-care standards.
GnRH agonists, antagonists and aromatase inhibitors require specialist oversight because of hypo-oestrogenic effects, bone-health considerations, add-back regimens and treatment duration. Do not copy a regimen from a web page into practice. Indian availability, approved indications and affordability vary, and no brand names are used in this educational draft. Patients actively trying to conceive need a different discussion: suppressive hormonal treatment prevents ovulation or otherwise conflicts with conception goals, so fertility planning should be explicit before a prescription is chosen.
When to Refer
Refer urgently for haemodynamic instability, suspected ectopic pregnancy, acute abdomen, peritonism, fever or sepsis concern, severe uncontrolled pain with vomiting or dehydration, urinary retention, bowel obstruction symptoms, a rapidly enlarging mass, or concern for torsion or malignancy. These presentations are not managed as routine endometriosis. Stabilisation and local emergency pathways take priority.
A planned gynaecology referral is appropriate when symptoms are severe, progressive, function-limiting, refractory to a reasonable initial plan, associated with an adnexal mass or suspected deep disease, or when imaging is abnormal or inconclusive in a way that will affect management. Referral is also appropriate when a patient requests diagnostic clarification after informed discussion. The referral should state the pain and bleeding history, fertility goals, prior medicines and response, examination findings, pregnancy-test result where applicable, imaging report and any red flags.
Refer to a centre with relevant expertise when deep endometriosis involving bowel, bladder, ureter, diaphragm or thorax is suspected, when complex pelvic surgery is contemplated, or when management may compromise ovarian reserve. ESHRE advises multidisciplinary discussion in a centre with sufficient expertise for extrapelvic disease. Fertility referral is reasonable when pregnancy is desired and there is a history of infertility, reduced ovarian reserve concerns, endometrioma, previous ovarian surgery or other couple factors.
A person who feels disbelieved, has disabling pain, or has anxiety or depression related to chronic symptoms also merits active support. Referral is not a failure of primary care; it is a means to combine symptom relief, diagnostic clarity and reproductive planning safely.
Red Flags
Do not attribute every pelvic symptom to endometriosis. Sudden severe unilateral pelvic pain, collapse, shoulder-tip pain, dizziness, fainting, heavy bleeding in a possible pregnancy, or positive pregnancy test with pain or bleeding require urgent evaluation for ectopic pregnancy, miscarriage, haemorrhage or ovarian torsion. Fever, purulent discharge, marked pelvic tenderness, vomiting, sepsis features or a toxic appearance require evaluation for pelvic infection or another acute abdominal process.
Bowel obstruction symptoms, persistent vomiting, abdominal distension, inability to pass stool or flatus, visible rectal bleeding unrelated to a known benign cause, significant haematuria, or new flank pain should prompt urgent assessment rather than a routine pain review. Catamenial chest symptoms, shoulder pain or breathlessness merit specialist assessment because extrapelvic disease is possible but serious thoracic and cardiopulmonary alternatives must be excluded.
Postmenopausal pelvic pain or a new pelvic mass should not be presumed benign. ESHRE advises that a pelvic mass in postmenopausal women be investigated and treated according to national oncology guidance because malignancy risk requires appropriate work-up. Persistent intermenstrual or postcoital bleeding, unexplained weight loss, iron-deficiency anaemia, palpable mass, or a change in bowel habit also require a wider differential.
Red flags are a triage concept, not a checklist that replaces examination. The patient should be advised to seek urgent local care for severe or rapidly worsening symptoms. In teaching, use these features to prioritise pregnancy testing, vital signs, examination, imaging and referral—not to memorise a diagnosis.
Indian Clinical Context
This guide does not imply that a current, condition-specific Indian national endometriosis guideline exists. The dated Indian primary source used here is the National Medical Commission 2024 CBME curriculum, which establishes the undergraduate learning expectations of history-taking, investigation interpretation, safe prescribing and timely referral in obstetrics and gynaecology. Diagnostic and treatment principles are therefore drawn from WHO and ESHRE guidance and must be adapted to local referral pathways, medicine availability and clinician judgement.
In India, access to transvaginal ultrasound, MRI, laparoscopy, fertility services, pelvic physiotherapy and multidisciplinary surgery may differ between settings. A safe pathway must therefore distinguish what can begin in primary or secondary care—history, examination with consent, pregnancy testing when indicated, basic investigations, pain support and referral—from what requires specialist services. Lack of immediate access to laparoscopy should not invalidate symptoms or prevent a reasoned clinical assessment. Conversely, limited access should not justify unsafe empiric treatment when red flags, a mass or a pregnancy-related emergency is possible. WHO specifically identifies gaps in access to multidisciplinary expertise in low- and middle-income settings.
Menstrual stigma, privacy concerns, cost and family pressure around fertility can affect disclosure and follow-up. Ask permission before discussing sexual pain or fertility, use clear non-stigmatising language and ensure the patient can state their own priorities. Avoid unsupported claims about Indian prevalence, dietary cures, traditional remedies, locally available brands or cost. If complementary practices are discussed, they should be framed as patient preferences to be reviewed for safety and interactions, not as substitutes for diagnosis or evidence-based care.
Referral documentation is especially valuable when services are fragmented. Include symptom chronology, menstrual and fertility goals, examination and imaging findings, prior treatment response and reasons for urgency. This improves continuity without overstating diagnostic certainty.
NMC Competency Mapping
The National Medical Commission 2024 CBME curriculum states that the undergraduate obstetrics and gynaecology learner should provide reproductive-health care, interpret laboratory and radiological investigations as they apply to obstetric and gynaecological care, prescribe drugs safely and appropriately, and identify conditions requiring timely referral. Endometriosis is a useful integrated teaching context for these outcomes because it requires history-taking, symptom interpretation, differential diagnosis, safe prescribing principles, informed consent and referral planning rather than recall of a single test.
At the Know level, learners should define endometriosis, recognise its common pain and fertility presentations, and state that imaging can support but a negative study does not exclude superficial disease. At the Know How level, learners should construct a differential for cyclical pelvic pain, identify the need for pregnancy testing where appropriate, interpret a pelvic-ultrasound report in context and explain why treatment goals differ when pregnancy is desired.
At the Show How level, a learner can take a sensitive menstrual, pain and fertility history in a simulated or supervised setting; explain examination and obtain consent; identify red flags; and communicate uncertainty without minimising symptoms. They should present a referral that includes relevant history, findings and the patient’s priorities. Prescription decisions, surgical choices and fertility interventions should be made under appropriate clinical supervision and within local policy.
This mapping deliberately does not invent a condition-specific NMC competency code. The cited curriculum establishes the subject-level capabilities; course teams should map it to their current institutional competency ledger before using it for formal assessment.
Key Exam Pearls for NEET PG
1. Think of endometriosis in dysmenorrhoea that is severe, progressive or function-limiting, especially with deep dyspareunia, dyschezia, cyclical urinary or bowel symptoms, chronic pelvic pain or infertility. A normal examination does not exclude it.
2. Transvaginal ultrasound is useful for endometrioma and some deep disease, but negative imaging does not exclude superficial peritoneal endometriosis. MRI is a problem-solving or mapping tool in selected cases; neither modality makes every case visible.
3. Routine blood, urine, saliva or menstrual-fluid biomarkers are not recommended to diagnose endometriosis. Avoid an exam answer that treats CA-125 or another biomarker as a stand-alone diagnostic test.
4. Laparoscopy is not compulsory before empiric symptom treatment in every patient. Consider it when imaging is negative and empirical treatment fails, is unsuitable, or when diagnosis and treatment will be combined.
5. Management is organised by symptoms, disease features and reproductive goals. Hormonal treatment may improve pain but is not a fertility-enhancing treatment for someone actively trying to conceive. Surgery may help selected patients, but recurrence and ovarian-reserve implications matter.
6. In any reproductive-age patient with pelvic pain, first exclude pregnancy-related emergencies. Sudden pain, syncope, shoulder-tip pain, shock, fever, peritonism or a concerning mass is a safety problem before it is an endometriosis question.
7. For viva answers, state shared decision-making: explain uncertainty, discuss analgesic and hormonal options where appropriate, address fertility plans, avoid unsupported cure claims, and refer complex deep disease or refractory symptoms to an experienced service.
Frequently Asked Questions
Why can endometriosis be missed for several years?
Symptoms vary widely, may overlap with bowel, bladder or primary menstrual-pain conditions, and can be normalised by patients, families or clinicians. WHO reports diagnostic delays of four to twelve years globally. A careful menstrual and pain history, attention to functional impact, appropriate imaging and planned follow-up can reduce avoidable delay. No single symptom, normal examination or negative ultrasound settles every case.
What is the first safety check for pelvic pain?
When pregnancy is possible, assess pregnancy status and symptoms that could indicate ectopic pregnancy or miscarriage before treating presumed endometriosis. Sudden severe pain, collapse, shoulder-tip pain, dizziness, significant bleeding or haemodynamic instability require urgent evaluation. The purpose is not to alarm every patient, but to prevent a time-critical pregnancy-related emergency from being missed.
Can endometriosis cause bowel and urinary symptoms?
Yes. Painful defaecation, bowel symptoms that vary with menstruation, dysuria, cyclical haematuria and deep dyspareunia can occur with endometriosis, particularly when disease affects pelvic structures. These symptoms are not specific, so bowel, urinary, infectious and malignant causes must also be considered. Persistent obstruction symptoms, visible bleeding or systemic illness need urgent assessment rather than self-treatment.
How should fertility wishes influence treatment decisions?
Fertility wishes should be discussed at the first meaningful management conversation because pain treatment, contraception, ovarian surgery and assisted reproduction have different implications. Hormonal suppression may help pain but is unsuitable when actively trying to conceive. Surgery can be useful in selected settings but may affect ovarian reserve. Referral decisions should consider duration of infertility, age, other couple factors and the patient’s priorities.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic